These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18264940)

  • 1. Associations between calcineurin inhibitors and arterial compliance in kidney transplant recipients.
    Wystrychowski G; Chudek J; Zukowska-Szczechowska E; Wiecek A; Grzeszczak W
    J Nephrol; 2008; 21(1):81-92. PubMed ID: 18264940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arterial elasticity measurement in renal transplant patients under anticalcineurin immunosuppression.
    Martínez-Castelao A; Sarrias X; Bestard O; Gil-Vernet S; Serón D; Cruzado JM; Moreso F; Díez-Noguera A; Grinyó JM
    Transplant Proc; 2005 Nov; 37(9):3788-90. PubMed ID: 16386539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulse wave analysis to assess vascular compliance changes in stable renal transplant recipients.
    Cohen DL; Warburton KM; Warren G; Bloom RD; Townsend RR
    Am J Hypertens; 2004 Mar; 17(3):209-12. PubMed ID: 15001192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of calcineurin inhibitors on pulse wave velocity in renal transplant recipients.
    Strózecki P; Adamowicz A; Włodarczyk Z; Manitius J
    Ren Fail; 2007; 29(6):679-84. PubMed ID: 17763162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of calcineurin inhibitors on urinary excretion of mycophenolic acid and its glucuronide in kidney transplant recipients.
    Naito T; Mino Y; Otsuka A; Ushiyama T; Ito T; Ozono S; Kagawa Y; Kawakami J
    J Clin Pharmacol; 2009 Jun; 49(6):710-8. PubMed ID: 19451405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of calcineurin inhibitors on extracellular matrix turnover in isolated human glomeruli.
    Esposito C; Foschi A; Parrilla B; Cornacchia F; Fasoli G; Plati AR; De Mauri A; Mazzullo T; Scudellaro R; Dal Canton A
    Transplant Proc; 2004 Apr; 36(3):695-7. PubMed ID: 15110634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of cyclosporine and tacrolimus on arterial function.
    Seibert F; Behrendt C; Schmidt S; van der Giet M; Zidek W; Westhoff TH
    Transpl Int; 2011 Jul; 24(7):708-15. PubMed ID: 21569126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired erythropoietin production in liver transplant recipients: the role of calcineurin inhibitors.
    Bardet V; Junior AP; Coste J; Lecoq-Lafon C; Chouzenoux S; Bernard D; Soubrane O; Lacombe C; Calmus Y; Conti F
    Liver Transpl; 2006 Nov; 12(11):1649-54. PubMed ID: 17058250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of regulatory T cells in kidney graft recipients: a relationship with calcineurin inhibitor level.
    Calvo-Turrubiartes M; Romano-Moreno S; García-Hernández M; Chevaile-Ramos JA; Layseca-Espinosa E; González-Amaro R; Portales-Pérez D
    Transpl Immunol; 2009 May; 21(1):43-9. PubMed ID: 19233271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-dependent effects of cadaveric renal transplantation on arterial compliance in patients with end-stage renal disease.
    Westhoff TH; Straub-Hohenbleicher H; Basdorf M; van der Giet S; Schmidt S; Offermann G; Schlattmann P; Zidek W; van der Giet M
    Transplantation; 2006 May; 81(10):1410-4. PubMed ID: 16732178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose metabolism in renal transplant recipients: effect of calcineurin inhibitor withdrawal and conversion to sirolimus.
    Teutonico A; Schena PF; Di Paolo S
    J Am Soc Nephrol; 2005 Oct; 16(10):3128-35. PubMed ID: 16107580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial elasticity measurement in renal transplant recipients.
    Yildiz A; Fazlioglu M; Ersoy A; Gullulu M; Gullulu S; Yurtkuran M
    Transplant Proc; 2007 Jun; 39(5):1455-7. PubMed ID: 17580160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic analysis of tacrolimus and cyclosporine in living-donor liver transplant patients.
    Fukudo M; Yano I; Masuda S; Fukatsu S; Katsura T; Ogura Y; Oike F; Takada Y; Tanaka K; Inui K
    Clin Pharmacol Ther; 2005 Aug; 78(2):168-81. PubMed ID: 16084851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting kidney-transplant outcome in recipients with lupus nephritis.
    Tang H; Chelamcharla M; Baird BC; Shihab FS; Koford JK; Goldfarb-Rumyantzev AS
    Clin Transplant; 2008; 22(3):263-72. PubMed ID: 18482047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in renal vascular resistance after intake of cyclosporin A and tacrolimus and reversal by nitroglycerin spray: a study in patients with stable renal allograft function.
    Weingart C; Leingärtner T; Bergler T; Krüger B; Böger C; Mack M; Banas B; Krämer BK
    Int J Clin Pharmacol Ther; 2006 Sep; 44(9):422-7. PubMed ID: 16995330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
    Schena FP; Pascoe MD; Alberu J; del Carmen Rial M; Oberbauer R; Brennan DC; Campistol JM; Racusen L; Polinsky MS; Goldberg-Alberts R; Li H; Scarola J; Neylan JF;
    Transplantation; 2009 Jan; 87(2):233-42. PubMed ID: 19155978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrophotometric assay for calcineurin activity in leukocytes isolated from human blood.
    Sellar KJ; van Rossum HH; Romijn FP; Smit NP; de Fijter JW; van Pelt J
    Anal Biochem; 2006 Nov; 358(1):104-10. PubMed ID: 16979577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in oxidative stress in renal graft patients receiving calcineurin inhibitors: cyclosporine versus tacrolimus.
    Akbasli AC; Keven K; Erbay B; Nebioglu S
    Exp Clin Transplant; 2012 Oct; 10(5):439-45. PubMed ID: 22817282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence.
    Vivarelli M; Cucchetti A; La Barba G; Ravaioli M; Del Gaudio M; Lauro A; Grazi GL; Pinna AD
    Ann Surg; 2008 Nov; 248(5):857-62. PubMed ID: 18948815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of different pharmacokinetics between cyclosporine and tacrolimus in renal transplant recipients: why cyclosporine is monitored by C2 level and tacrolimus by trough level.
    Takeuchi H; Matsuno N; Hirano T; Toraishi T; Konno O; Nakamura Y; Iwamoto H; Hama K; Unezaki S; Nagao T
    Transplant Proc; 2008 Sep; 40(7):2240-2. PubMed ID: 18790203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.